Rejoni gets FDA approval for Juveena Hydrogel System
The U.S. FDA granted Premarket Approval for Rejoni's Juveena Hydrogel System to reduce intrauterine adhesions after hysteroscopic adhesiolysis. Rejoni said it will begin a limited U.S. market release at select centers, then broaden rollout.